ChemoCentryx, Inc.
ChemoCentryx, Inc. (CCXI): 2 pipeline candidates · ~37 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
36.8 months
D/E 0.77 · 0% dilution
Lead: Preclinical
2 candidates
N/A
N/A
A transparent, data-derived signal for ChemoCentryx, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$573.7M
Cash
$45.5M
Quarterly Burn
$26.1M
Runway
36.8 mo
Revenue
$11.8M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (2 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
41
Total value held
$143.5M
| Holder | Shares | Value |
|---|---|---|
| adage capital partners gp, l.l.c. | 2,700,000 | $27.4M |
| d. e. shaw & co., inc. | 1,297,180 | $13.2M |
| moore capital management, lp | 1,000,000 | $10.2M |
| healthcare of ontario pension plan trust fund | 750,000 | $7.6M |
| picton mahoney asset management | 750,000 | $7.6M |
| tenor capital management co., l.p. | 750,000 | $7.6M |
| two sigma investments, lp | 652,500 | $6.6M |
| hudson bay capital management lp | 650,000 | $6.6M |
| verition fund management llc | 611,375 | $6.2M |
| shaolin capital management llc | 514,037 | $5.2M |
Showing top 10 of 41 institutional holders of ChemoCentryx, Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in ChemoCentryx, Inc.'s pipeline?
ChemoCentryx, Inc. (CCXI) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is ChemoCentryx, Inc.'s lead drug candidate?
ChemoCentryx, Inc.'s most advanced tracked candidate is ccx559 (Preclinical) for Various cancers.
What is ChemoCentryx, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, ChemoCentryx, Inc. has approximately 36.8 months of cash runway.
What is ChemoCentryx, Inc.'s market capitalization?
ChemoCentryx, Inc.'s market capitalization is approximately $573.7M.
Who is the CEO of ChemoCentryx, Inc.?
Mr. Michael S. Klein is the chief executive officer of ChemoCentryx, Inc. (CCXI).
Get the full picture on ChemoCentryx, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.